Skip to main content

Table 2 Detection atrial fibrillation and the effect of treatment in the two monitoring groups

From: Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial

OutcomePatch-based monitoring (ACTIVE)
(n = 43)
Short-duration Holter (CONTROL)
(n = 47)
P valueOdds ratio (95% CI)
Number (percentage)
Primary outcome
 Detection of PAF with duration ≥ 30 s at 90 days (inter-subject comparison)7 (16.3)1 (2.1)0.0268.9 (1.1–76.0)
Secondary outcomes
 Detection of PAF with duration ≥ 30 s at 28 days6 (14.0)1 (2.1)0.0517.5 (0.9–64.7)
 Anticoagulation therapy use at 90 days7 (16.3)1 (2.1)0.0268.9 (1.1–76.0)
 Second ischaemic stroke or TIA at 90 days1 (2.3)1 (2.1)1.001.1 (0.1–18.1)
 Mortality at 90 days1 (2.3)0 (0)0.48
  1. PAF paroxysmal atrial fibrillation, TIA transient ischaemic attack